Rapid, low-sample-volume cholesterol and triglyceride assays
AssigneeTheranos, Inc.
InventorsDouglas Matje, Ian Gibbons, Paul Patel, Elizabeth A. Holmes
Life of this patent
Estimating the term…
Loading patent…
AssigneeTheranos, Inc.
InventorsDouglas Matje, Ian Gibbons, Paul Patel, Elizabeth A. Holmes
Estimating the term…
Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed. Assays may be performed in a single reaction mixture, allowing more accurate and precise cholesterol determinations, including ratios of cholesterol sub-fractions to total cholesterol, at less expense, than would be expected by performing several different assays in different reaction mixtures.
A method for the measurement of at least two lipoprotein components in a blood sample from a subject, wherein said at least two lipoprotein components are selected from total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol (HDL-C), said method comprising:
(canceled)
(canceled)
A method for the combined measurement of high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), total cholesterol (TC), and triglyceride level (TG) in no more than two samples of blood from a subject, said method comprising:
(canceled)
16-19. (canceled)
A reagent for use in a cholesterol assay, said reagent comprising a lipoprotein solubilization agent, lipoprotein interactant, and a buffer, wherein said lipoprotein interactant is present at a concentration level that provides for conversion of high density lipoprotein cholesterol (HDL-C) to a measureable colored product at a substantially different rate than for conversion of low density lipoprotein cholesterol (LDL-C) to a measureable colored product and at a substantially different rate than for conversion of very low density lipoprotein cholesterol (VLDL-C) to a measureable colored product.
24-25. (canceled)
A reagent for use in an assay for the measurement of at least two of total cholesterol, low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) in lipoproteins in a sample of blood from a subject without substantial precipitation of said lipoproteins, comprising a buffer, an amphiphilic agent, a lipase comprising a cholesterol esterase, an oxidase comprising a cholesterol oxidase, a peroxidase, and a colorant.
(canceled)
(canceled)
Dependencies are inferred from the claim text.